Drug Trial Radar · NCT02725060
Autoimmune Basis for Postural Tachycardia Syndrome
Last checked: Nov 20, 2026Latest source record: Nov 10, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
58
Planned (sponsor's estimate)
Start
Feb 2016
Primary completion
Feb 2027
Study completion Jun 2027
Sponsor
- Lead sponsor
- Vanderbilt University Medical CenterAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- University of Oklahoma
- First posted
- Mar 31, 2016
Design
- Study type
- Interventional
- Phase
- Not applicable
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Other
- Who can join
- All sexes, from 18 years, up to 50 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The purpose of this study is to see if some people with postural tachycardia syndrome (POTS) have higher levels of immune proteins (autoantibodies) directed against receptors of the autonomic nervous system, and if these autoantibodies make a difference in their POTS symptoms. The investigators also want to see if the levels of these autoantibodies stay the same over time.
Conditions
- Postural Orthostatic Tachycardia Syndrome
- Postural Tachycardia Syndrome
- Tachycardia
- Arrhythmias, Cardiac
- Autonomic Nervous System Diseases
- Orthostatic Intolerance
- Cardiovascular Diseases
- Primary Dysautonomias
Interventions
phenylephrineDrug
Phenylephrine is a selective α1-adrenergic receptor agonist. It will be given in IV bolus injections starting from 12.5 ug. Incremental doses will be given every \~3 min up to 800 ug or until systolic blood pressure increases by 25 mmHg
isoproterenolDrug
Isoproterenol is non-selective beta-adrenergic agonist. It will be given in IV bolus injections starting from 0.025 ug. Incremental doses will be given every \~3 min until heart rate increases by 25 bpm. This intervention is optional.
25 micro-Ci of radiationRadiation
Using injection of iodinated I-131 tagged human serum albumin nominally 25 micro-Ci of radiation, blood samples are drawn before and 30 minutes after injection.
Posture study with blood samplesProcedure
Blood pressure and heart rate will be measured while supine and then while standing for up to 30 minutes. Blood will be drawn in each position to measure hormones that regulate blood pressure and blood volume. An additional sample will be collected in the supine position for the autoantibody assessment.
24-hour heart rhythm and blood pressure monitoringProcedure
Blood pressure, heart rate and ECG monitoring for 24 hours
Quantitative Axonal Sudomotor Reflex TestingProcedure
The QSART assesses the ability of sympathetic nerve terminals in the skin to release acetylcholine and increase sweat production. The test is performed at 4 sites over the forearm, proximal lateral leg, medial distal leg and proximal foot.
Autonomic function testsProcedure
The autonomic function tests will determine how well the autonomic nervous system regulates blood pressure and heart rate. These tests include breathing deeply for two minutes, breathing fast for 30 seconds, maintaining a handgrip for 3 minutes, breathing against pressure for 15 seconds, and placing the hand in ice water for 1 minute. In addition, participants will be tilted up on a tilt table for up to 10 minutes while recording their heart rate, blood pressure and cardiac output.
Rebreathing testOther
Cardiac output will be measured using the rebreathing technique (Innocor)
Assessment of splanchnic capacitanceOther
Splanchnic capacitance will be assessed using cpap and body impedance to construct pressure volume curves
microneurographyProcedure
microneurography will be measured in the peroneal nerve to assess sympathetic activity.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Autoantibody levelsTime frame: up to 10 minutes
- Blood pressure after phenylephrine bolusesTime frame: 1-2 minutes after bolus injections
- Heart rate after isoproterenol bolusesTime frame: 1-2 minutes after bolus injections
- Orthostatic change in heart rateTime frame: up to 10 minutes
Locations
2 sites in 1 country. Site status is shown where the registry gives one.
University of Oklahoma Health Sciences Center
Oklahoma City, Oklahoma
Autonomic Dysfunction Center
Nashville, Tennessee
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.